US Stock MarketDetailed Quotes
EPRX Eupraxia Pharmaceuticals
- 3.450
- +0.400+13.11%
Close Nov 27 16:00 ET
- 3.450
- 0.0000.00%
Post 20:01 ET
122.90MMarket Cap-3709P/E (TTM)
3.560High3.060Low5.70KVolume3.060Open3.050Pre Close18.89KTurnover0.02%Turnover RatioLossP/E (Static)35.62MShares4.08052wk High12.92P/B88.23MFloat Cap2.20052wk Low--Dividend TTM25.57MShs Float4.080Historical High--Div YieldTTM16.39%Amplitude2.200Historical Low3.317Avg Price1Lot Size
About Eupraxia Pharmaceuticals Company
Eupraxia Pharmaceuticals, Inc. operates as a drug delivery technology company in Canada. It delivers drugs into body compartments, such as the joint without any of the common issues with body compartment injections, such as systemic exposure. The firm focuses on arthritis, diabetic macular edema, and chronic pain programs. The company was founded by James A. Helliwell and John Salvatore Montalbano on May 12, 2011 and is headquartered in Victoria, Canada.
Company Profile
SymbolEPRX
Company NameEupraxia Pharmaceuticals
Founded2011
CEODr. James A. Helliwell, M.D.
MarketNASDAQ
Employees29
Fiscal Year Ends12-31
Address2067 Cadboro Bay Road,Suite 201
CityVictoria
ProvinceBritish Columbia
CountryCanada
Zip CodeV8R 5G4
Phone1-250-590-3968
Company Executives
- Name
- Position
- Salary
- Dr. James A. Helliwell, M.D.
- Chief Executive Officer and Director
- 517.30K
- Bruce G. Cousins
- Chief Financial Officer and President
- 368.72K
- Dr. Mark Kowalski, M.D.,Pd.D
- Chief Medical Officer
- 988.79K
- Dr. Amanda Malone
- Chief Scientific Officer and Chief Operating Officer
- 368.72K
- Paul Brennan
- Chief Business Officer
- 343.12K
- Dr. Simon Pione, F.R.C.P.C,M.D.,PhD
- Chairman of the Board
- 42.23K
- John S. Montalbano, C.F.A.
- Independent Director
- 29.86K
- Dr. Richard M. Glickman,L.L.D.
- Independent Director
- 29.86K
- Dr. Michael Wilmink, M.D.
- Independent Director
- 23.56K
- Paul L. Geyer, P. Eng.
- Independent Director
- 23.56K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
